Article History
Accepted: 10 June 2021
First Online: 24 July 2021
Declarations
:
: This article received no funding.
: Stephan Jacob: Honoraria, research support and consulting fees from Amgen, AstraZeneca, Bayer, Berlin-Chemie, Boehringer Ingelheim, Daiichi Sankyo, Esanum, Eli Lilly, Medcon, Merck, MSD, Novartis, Novo Nordisk, Roche, Sanofi-Aventis, Servier. Andrew Krentz: Lecture fees from Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Novo Nordisk, Merck, Pfizer, Servier, Takeda. Research grants from Fujisawa, Pfizer, Servier, Novo Nordisk. John Deanfield: Received CME honoraria and/or consulting fees from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk, Bayer. Member of Study Steering Committees for Novo Nordisk. Research grants from British Heart Foundation, MRC(UK), NIHR, PHE, MSD, Pfizer, Aegerion, Colgate, Roche. Lars Ryden: Advisory Board/Speaker: AstraZeneca, Bayer AG, Boehringer Ingelheim, MSD, Novo Nordisk, Sanofi-Aventis. Research support: Swedish Heart-Lung Foundation, Swedish Diabetes Foundation, Family Erling Perssons Foundation, Karolinska Institutet, Private Foundations,Stockholm County Council, Swedish Medical Assembly, Amgen, Bayer, Boehringer Ingelheim, MSD, Novo Nordisk.
: Not applicable.